This is a preview of subscription content, log in via an institution to check access.
Reference
Bristol-Myers Squibb. CANADA'S HEALTH TECHNOLOGY ASSESSMENT AGENCY GIVES POSITIVE RECOMMENDATION FOR OPDIVO(TM) TO TREAT NON-SMALL CELL LUNG CANCER. Media Release : 8 Jun 2016. Available from: URL: http://www.bmscanada.ca
Rights and permissions
About this article
Cite this article
Nivolumab recommended for NSCLC in Canada. PharmacoEcon Outcomes News 755, 42 (2016). https://doi.org/10.1007/s40274-016-3149-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3149-3